m(6)A Regulator-Mediated Methylation Modification Model Predicts Prognosis, Tumor Microenvironment Characterizations and Response to Immunotherapies of Clear Cell Renal Cell Carcinoma

BACKGROUND: This study aims to establish an N6-methyladenosine (m(6)A) RNA methylation regulators-mediated methylation model and explore its role in predicting prognostic accuracy of immune contexture and characterizations of clear cell renal cell carcinoma (ccRCC). METHODS: The m(6)A modification s...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Oncol
Auteurs principaux: Xu, Wenhao, Tian, Xi, Liu, Wangrui, Anwaier, Aihetaimujiang, Su, Jiaqi, Zhu, Wenkai, Wan, Fangning, Shi, Guohai, Wei, Gaomeng, Qu, Yuanyuan, Zhang, Hailiang, Ye, Dingwei
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2021
Sujets:
Oncology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8290143/
https://ncbi.nlm.nih.gov/pubmed/34295828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.709579
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires